Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression
Masanori Takehara,Yasushi Sato,Tetsuo Kimura,Kazuyoshi Noda,Hiroshi Miyamoto,Yasuteru Fujino,Jinsei Miyoshi,Fumika Nakamura,Hironori Wada,Yoshimi Bando,Tetsuya Ikemoto,Mitsuo Shimada,Naoki Muguruma,Tetsuji Takayama
DOI: https://doi.org/10.1111/cas.14527
IF: 5.7
2020-07-06
Cancer Science
Abstract:<p>Although pancreatic cancer often invades into peripancreatic adipose tissue, little is known about the cancer‐adipocyte interaction. We first investigated the ability of adipocytes to de‐differentiate to cancer‐associated adipocytes (CAAs) by co‐culturing with pancreatic cancer cells. We then examined the effects of CAA‐conditioned media (CAA‐CM) on the malignant characteristics of cancer cells, the mechanism underlying those effects<b>, </b> and their clinical relevance in pancreatic cancer. When 3T3‐L1 adipocytes were co‐cultured with pancreatic cancer cells (PANC‐1) using Transwell system, adipocytes lost their lipid droplets and morphologically changed to fibroblast‐like cells (CAA). Adipocyte‐specific marker mRNA levels significantly decreased but those of fibroblast‐specific markers <span>appeared</span>, characteristic findings of CAA, as revealed by real‐time PCR. When PANC‐1 cells were cultured with CAA‐CM, significantly higher migration/invasion capability, chemoresistance, and epithelial‐mesenchymal transition (EMT) properties were observed compared with control cells. To investigate the mechanism underlying these effects, we performed microarray analysis of PANC‐1 cells cultured with CAA‐CM, and found 78.5‐fold higher expression of SAA1 compared with control cells. When SAA1 gene in PANC‐1 cells was knocked down with SAA1 siRNA, migration/invasion capability, chemoresistance, and EMT properties were significantly attenuated compared with control cells. Immunohistochemical analysis on human pancreatic cancer tissues revealed positive SAA1 expression in 46/61 (75.4%). Overall survival in the SAA1‐positive group was significantly shorter than in the SAA1‐negative group (p=0.013). In conclusion, we demonstrated that pancreatic cancer cells induced de‐differentiation in adipocytes toward CAA, and CAA promoted malignant characteristics of pancreatic cancer via SAA1 expression, suggesting that SAA1 is a novel therapeutic target in pancreatic cancer.</p>
oncology